Jeffrey S. Aronin

CNS pipeline · person

Jeffrey S. Aronin

Founder and Chairman of Emalex Biosciences and a bioscience entrepreneur known for developing and commercializing novel neurology medicines. In 2017 he founded Paragon Biosciences, where he is Chairman and CEO; Paragon's portfolio includes Harmony Biosciences (NASDAQ: HRMY), Emalex Biosciences and CiRC Biosciences. He sits on corporate and civic boards including The Aspen Institute and the Weizmann Institute of Science and served 14 years on the Discover Financial Services board.

  • 1 company

Courtesy Emalex Biosciences

Current roles

Appears with

People sharing a company with Jeffrey.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.